Recombinant Human CD27 Ligand/TNFSF7 Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 9328-CL

Analyzed by SEC-MALS
R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
9328-CL-100
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

HEK293

Accession #

P32970.2

Structure / Form

Noncovalently-linked homotrimer

Conjugate

Unconjugated

Applications

Bioactivity

View all CD27 Ligand/TNFSF7 Proteins and Enzymes »

Product Specifications

Source

Human embryonic kidney cell, HEK293-derived human CD27 Ligand/TNFSF7 protein
HA
(YPYDVPDYA)		 GCN4-IZ GGGSGGGSGGGS Human CD27 Ligand
(Gln39-Pro193)
Accession # P32970.2
N-terminus C-terminus

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Tyr

Predicted Molecular Mass

23 kDa

SDS-PAGE

24-32 kDa, reducing conditions

Activity

Measured by its ability to induce IL-8 secretion in HT1080 human fibrosarcoma cells transfected with human CD27.
The ED50 for this effect is 5-25 ng/mL in the presence of Mouse Anti-Hemagglutinin/HA Peptide Monoclonal Antibody (Catalog # MAB060).

Reviewed Applications

Read 1 review rated 5 using 9328-CL in the following applications:

Scientific Data Images for Recombinant Human CD27 Ligand/TNFSF7 Protein, CF

Recombinant Human CD27 Ligand/TNFSF7 Protein SEC-MALS.

Recombinant Human CD27 Ligand/TNFSF7 (Catalog # 9328-CL) has a molecular weight (MW) of 72.4 kDa as analyzed by SEC-MALS, suggesting that this protein is a homotrimer. MW may differ from predicted MW due to post-translational modifications (PTMs) present (i.e. Glycosylation).
Recombinant Human CD27 Ligand/TNFSF7 Protein Bioactivity

Recombinant Human CD27 Ligand/TNFSF7 Protein Bioactivity

Recombinant Human CD27 Ligand/TNFSF7 (Catalog # 9328-CL) induces IL-8 secretion in HT1080 human fibrosarcoma cells transfected with Human CD27. The ED50 for this effect is 5-25 ng/mL.

Formulation, Preparation and Storage

9328-CL
Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution
Reconstitute at 200 μg/mL in PBS.

Reconstitution Buffer Available:
Size / Price
Qty
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CD27 Ligand/TNFSF7

CD27 ligand (CD27L), also named CD70, is a type II transmembrane glycoprotein belonging to the TNF superfamily (TNFSF) and has been designated TNFSF7 (1, 2). Human CD27L cDNA encodes a 193 amino acid (aa) residue protein with a 17 aa N-terminal cytoplasmic domain, a 21 aa transmembrane domain and a 155 aa C-terminal extracellular domain. Human and mouse CD27L share approximated 56% aa sequence identity. CD27L is expected to exist as non-covalent homotrimers. CD70 is constitutively expressed on medullary thymic epithelial cells (mTECs) in human and mouse and on certain unconventional APCs in the mouse intestine (3). CD70 is also exclusively expressed on DCs (5), B cells (5), conventional- and regulatory T cells (6) and NK cells (7) but only after their activation. CD70 expression is highly regulated by antigen through Pattern Recognition Receptors (PRRs), T cell and B cell antigen receptors (8), and further tuned by cytokines such as IL-1 alpha,
IL-12, TNF alpha, prostaglandin E2 and by CD28 and CD40 co-stimulation (9).  Ligation of CD27 on T cells provides co-stimulatory signals and promotes T cell proliferation, antigen-specific CD4+ and CD8+ T cells clonal expansion, effector & memory T-cell differentiation, and effector T-cell survival & T-cell memory formation (10-12). Ligation of CD27 on mouse B cell and NK cells promotes the B- and NK-cell response by supporting B-cell expansion in the germinal center and increasing IFN-gamma levels in NK cells, in turn enhancing NK cytotoxic capability, which can contribute to tumor control (13,14). Overall, CD27/CD70 co-stimulatory system promote T, B and NK cell responses and particularly the CTL response, and is a target in cancer immunotherapy (15).

References

  1. Bowman MR. et al. J Immunol. (1994) 152:1756.
  2. Croft, M. (2003) Nature Reviews Immunol. 3:609.
  3. Tesselaar K. et al. (2003) J. Immunol. 170:33.
  4. Sanchez PJ. et al. (2007) J. Immunol. 178:1564.
  5. Lens SM. et al. (1998) Semin. Immunol. 10:491.
  6. Koenen HJ. et al. (2005) J. Immunol. 174:7573.
  7. Hintzen RQ. et al. (1994) Int. Immunol. 6:477.
  8. Borst J. et al. (2005) Curr. Opin. Immunol. 17:275.
  9. Krause P. et al. (2009) Blood 113:2451.
  10. Van Gisbergen K. et al. (2011) Immunity 35:97.
  11. Peperzak V. et al. (2010) J. Immunol. 185:6670.
  12. Pen JJ. et al. (2013) J. Immunol. 191:1976.
  13. Shin CA, et al. (2016) Oncotarget 7:46173.
  14. Takeda K. et al. (2000) J. Immunol. 164:1741.
  15. Wajant H. (2016) Expert Opin Ther Targets 20:959.

Alternate Names

CD70, TNFSF7

Entrez Gene IDs

970 (Human); 21948 (Mouse); 301132 (Rat)

Gene Symbol

CD70

UniProt

P32970.2

Additional CD27 Ligand/TNFSF7 Products

Product Documents for Recombinant Human CD27 Ligand/TNFSF7 Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human CD27 Ligand/TNFSF7 Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.